درباره این اپیزود
Last week, advertising and legal professionals, experts, regulators, and business representatives convened in New York for the annual National Advertising Division (NAD) Conference to consider hot topics, share perspectives on emerging issues, and discuss best practices for navigating a dynamic regulatory landscape. This year, trending topics included endorsements and reviews (especially in light of the FTC’s recently-issued rule on fake reviews), dark patterns, claim substantiation, artificial intelligence, and FTC enforcement priorities. Keynote speakers included FTC Commissioner Melissa Holyoak and the Director of the FTC’s Bureau of Consumer Protection, Samuel Levine, who addressed FTC positions and recent actions on a number of emerging issues in advertising law. In addition, John Villafranco led a conversation with BBB Executive Vice President Mary Engle addressing the impact of FTC guidance on NAD decisions.
https://www.kelleydrye.com/viewpoints/blogs/ad-law-access/highlights-from-the-2024-national-advertising-division-conference
Donnelly McDowell
dmcdowell@kelleydrye.com
(202) 342-8645
www.kelleydrye.com/people/donnelly-l-mcdowell
Ioana Gorecki
igorecki@kelleydrye.com
(202) 342-8417
www.kelleydrye.com/people/ioana-gorecki
Cristina Ferretti
cferretti@kelleydrye.com
(212) 808-5057
www.kelleydrye.com/people/cristina-ferretti
Andrea deLorimier
adelorimier@kelleydrye.com
(202) 945-6642
www.kelleydrye.com/people/andrea-delorimier
Hosted by Simone Roach
Subscribe to the Ad Law Access blog - www.kelleydrye.com/subscribe
Subscribe to the Ad Law News Newsletter - www.kelleydrye.com/subscribe
View the Advertising and Privacy Law Resource Center - www.kelleydrye.com/advertising-and-privacy-law
Find all of our links here linktr.ee/KelleyDryeAdLaw
https://www.kelleydrye.com/viewpoints/blogs/ad-law-access/highlights-from-the-2024-national-advertising-division-conference
Donnelly McDowell
dmcdowell@kelleydrye.com
(202) 342-8645
www.kelleydrye.com/people/donnelly-l-mcdowell
Ioana Gorecki
igorecki@kelleydrye.com
(202) 342-8417
www.kelleydrye.com/people/ioana-gorecki
Cristina Ferretti
cferretti@kelleydrye.com
(212) 808-5057
www.kelleydrye.com/people/cristina-ferretti
Andrea deLorimier
adelorimier@kelleydrye.com
(202) 945-6642
www.kelleydrye.com/people/andrea-delorimier
Hosted by Simone Roach
Subscribe to the Ad Law Access blog - www.kelleydrye.com/subscribe
Subscribe to the Ad Law News Newsletter - www.kelleydrye.com/subscribe
View the Advertising and Privacy Law Resource Center - www.kelleydrye.com/advertising-and-privacy-law
Find all of our links here linktr.ee/KelleyDryeAdLaw
انگلیسی
ایالات متحده آمریکا
در این اپیزود
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Kelley Drye Ad Law Access Podcast را جستجو کن.
قسمت های دیگر در این پادکست
What’s the difference between hard-hitting marketing and misleading pricing claims? In this episode, we unpack a recent NAD decision involving Harry’s and Gillette that explores the boundaries of comparative advertising, including when advertisers can rely on regular retail prices instead of tempor…
What did July reveal about the future of advertising law and consumer protection? In this Summer Edition of the Ad Law Access Podcast, we take a step back from the month’s individual developments to explore the bigger trends shaping the legal landscape, from the application of traditional advertisi…
What happens when the FTC says “cancel” should actually mean cancel? In this episode, we unpack the FTC’s lawsuit against Uber, which alleges the company enrolled consumers in its Uber One subscription without obtaining proper consent, made misleading savings claims, and created an unnecessarily co…
What are state attorneys general preparing to tackle next—and what should businesses be watching? In this episode, we recap key takeaways from the 2026 Attorneys General Alliance Annual Meeting, where state AGs, regulators, and industry leaders focused on the rapid evolution of AI, privacy, pricing…
What happens when an FDA advisory committee recommends opening the door to peptide compounding, but FDA staff strongly disagree? In this episode, we unpack the FDA Pharmacy Compounding Advisory Committee’s recommendation to add six of seven peptides under review to the 503A Bulks List for uses rang…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Kelley Drye Advertising Law است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
